Askari Bank Limited (PSX:AKBL)

CTI BioPharma Balance Sheet

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	75,192	53,072	50,464	36,078	32,723	32,634
Investment Securities	1,660,810	1,498,754	1,181,931	762,710	616,231	415,713
Trading Asset Securities	9,042	10,674	566.54	404.07	341.82	0.19
Total Investments	1,669,852	1,509,428	1,182,498	763,114	616,573	415,713
Gross Loans	595,149	733,780	662,691	616,497	508,521	422,350
Allowance for Loan Losses	-36,814	-32,341	-28,175	-31,123	-30,228	-26,446
Other Adjustments to Gross Loans	-	-1,239	-1,470	-1,562	-619.36	-487.94
Net Loans	558,335	700,200	633,046	583,811	477,673	395,416
Property, Plant & Equipment	35,128	34,031	27,020	24,484	20,179	21,233
Other Intangible Assets	1,856	1,850	1,861	1,376	1,189	1,159
Accrued Interest Receivable	90,264	66,794	75,723	38,458	19,556	17,962
Other Receivables	1,264	419.46	512.53	490.66	669.01	7.37
Restricted Cash	78,307	93,423	124,385	44,549	60,266	49,214
Other Current Assets	40,228	35,143	20,830	23,334	21,730	18,507
Long-Term Deferred Tax Assets	918.23	-	8,065	7,546	5,162	1,597
Other Real Estate Owned & Foreclosed	602.23	991.12	866.81	1,983	3,167	4,869
Other Long-Term Assets	1,206	1,099	502.19	457.75	441.82	34,575
Total Assets	2,557,954	2,501,382	2,125,773	1,525,681	1,259,329	992,887
Accounts Payable	2,396	2,867	1,462	-	-	-
Accrued Expenses	7,164	8,343	6,767	4,702	4,978	4,218
Interest Bearing Deposits	1,002,982	974,919	939,468	792,867	706,040	539,727
Non-Interest Bearing Deposits	383,672	387,931	353,327	349,708	309,123	251,255
Total Deposits	1,386,654	1,362,851	1,292,795	1,142,575	1,015,162	790,982
Short-Term Borrowings	913,874	718,960	613,084	203,679	93,466	57,451
Current Portion of Long-Term Debt	-	130,754	5,017	4,624	8,675	6,466
Current Portion of Leases	1,134	1,091	1,144	-	-	-
Accrued Interest Payable	15,916	13,749	23,387	11,701	4,804	4,011
Other Current Liabilities	42,476	83,850	26,642	27,000	25,041	24,617
Long-Term Debt	36,593	32,163	38,583	37,241	33,423	32,475
Long-Term Leases	13,612	13,084	8,556	8,084	7,394	8,224
Long-Term Unearned Revenue	2,070	1,632	2,003	2,485	2,294	1,727
Pension & Post-Retirement Benefits	-	-	67.47	194.71	280.29	313.3
Long-Term Deferred Tax Liabilities	-	258.34	-	-	-	-
Other Long-Term Liabilities	12,585	8,890	8,570	10,064	7,042	7,720
Total Liabilities	2,434,473	2,378,971	2,028,077	1,452,349	1,203,288	938,205
Common Stock	14,493	14,493	14,493	12,603	12,603	12,603
Additional Paid-In Capital	-	-	-	234.67	234.67	234.67
Retained Earnings	92,176	89,222	76,327	55,350	40,666	33,888
Comprehensive Income & Other	16,354	18,226	6,499	5,145	2,537	7,956
Total Common Equity	123,022	121,941	97,319	73,332	56,041	54,681
Minority Interest	459.19	469.34	376.7	-	-	-
Shareholders' Equity	123,482	122,410	97,696	73,332	56,041	54,681
Total Liabilities & Equity	2,557,954	2,501,382	2,125,773	1,525,681	1,259,329	992,887
Total Debt	965,212	896,052	666,385	253,627	142,958	104,616
Net Cash (Debt)	-862,273	-832,246	-615,355	-216,738	-109,893	-71,982
Net Cash Per Share	-594.96	-574.24	-424.59	-149.55	-75.83	-49.67
Filing Date Shares Outstanding	1,449	1,449	1,449	1,449	1,449	1,449
Total Common Shares Outstanding	1,449	1,449	1,449	1,449	1,449	1,449
Book Value Per Share	84.88	84.14	67.15	50.60	38.67	37.73
Tangible Book Value	121,166	120,091	95,458	71,957	54,852	53,522
Tangible Book Value Per Share	83.60	82.86	65.87	49.65	37.85	36.93

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.